🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The purpose of this study is to determine whether the plasticity of autolog...
Status
Completed
Location
Hospital Universitario Dr. Jose E. Gonzalez
Start Date
2009-07
Trial ID
NCT01019733
Treatments Being Tested
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2004-01-22
Trial ID
NCT00052884
The objective of this research is to measure certain indicators of resilien...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-09-28
Trial ID
NCT04188678
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1992-10
Trial ID
NCT00002515
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00417053
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This study will investigate whether the treatment of damaged cartilage in t...
Status
Completed
Location
Sports Medicine Centre - University of Calgary
Start Date
2005-12
Trial ID
NCT00314236
Treatments Being Tested
A Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZ...
Status
Terminated
Location
Research Site
Start Date
2014-03
Trial ID
NCT02087176
Treatments Being Tested